drugset / Trial / NCT06422039
Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This study was designed as a a single-center, randomized, open, interleaved (3-cycle, 3-sequence) trial. It is planned to enroll 18 healthy subjects.
Timeline
- Start
- 2024-05-23
- Primary completion
- 2024-08-06
- Completion
- 2024-08-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-7535 | Small molecule | — | — |